Career Enhancement Core of GLIA-CTN

GLIA-CTN 职业提升核心

基本信息

项目摘要

Abstract The Global Leukodystrophy Initiative (GLIA) has made education and improved standards of care a key aspect of their mission. We acknowledge the importance of education and outreach related to the leukodystrophies across stakeholders, including patients, families, primary care providers and specialty providers. The GLIA consortium has published the only current comprehensive recommendations for standards of care across these conditions. Our investigators and their institutions have a longstanding commitment to educational efforts and community outreach. Advocacy partners participating in the GLIA Clinical Trials Network (GLIA-CTN) are also strong advocates for improved education. The GLIA-CTN career development program will leverage the input of the patient advocacy groups and our investigators to enhance knowledge of leukodystrophies within the community. Although a full resolution of educational needs in the leukodystrophy community is beyond the scope of this application, the GLIA-CTN will lay the groundwork for development of a multi-stakeholder educational approach through the following aims: Educational Aim 1: to develop a process to integrate relevant stakeholder input on development of educational programs including clinicians, researchers, patients and their families/ caregivers. Educational Aim 2: to establish a clinical investigator training program in the leukodystrophies to attract and train the next generation of researchers to advancing the care of individuals affected by the leukodystrophies.
摘要 全球脑白质营养不良倡议(GIIA)已将教育和提高护理标准作为关键 这是他们使命的一部分。我们认识到教育和宣传工作的重要性。 跨利益相关者的脑白质营养不良,包括患者、家庭、初级保健提供者和专科 供应商。Glia财团已经发布了目前唯一的全面建议 这些情况下的护理标准。我们的调查人员和他们的机构长期以来 致力于教育工作和社区外展。参与全球法律援助框架的倡导伙伴 临床试验网络(GILA-CTN)也是改善教育的强烈倡导者。Glia-CTN的职业生涯 开发计划将利用患者权益倡导团体和我们的调查人员的投入来增强 社区内的脑白质营养不良知识。尽管教育需求的全面解决 脑白质营养不良社区超出了这一应用范围,将为胶质细胞CTN的研究奠定基础 通过以下目标制定多方利益攸关方教育方法: 教育目标1:制定一个程序,以整合相关利益攸关方对发展的意见 教育项目包括临床医生、研究人员、患者及其家人/照顾者。 教育目标2:建立脑白质营养不良的临床研究人员培训计划,以吸引和 培训下一代研究人员,以促进对受脑白质营养不良影响的个人的护理。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Adeline Lucie Vanderver其他文献

Adeline Lucie Vanderver的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Adeline Lucie Vanderver', 18)}}的其他基金

GLIA-CTN Genomic Expert Curation Panel
GLIA-CTN 基因组专家管理小组
  • 批准号:
    10630404
  • 财政年份:
    2023
  • 资助金额:
    $ 12.42万
  • 项目类别:
Reverse transcriptase inhibition as a novel therapeutic approach for ADAR-1-related Aicardi Goutières Syndrome
逆转录酶抑制作为 ADAR-1 相关 Aicardi Goutières 综合征的新型治疗方法
  • 批准号:
    10288270
  • 财政年份:
    2022
  • 资助金额:
    $ 12.42万
  • 项目类别:
Improved clinical and biologic outcome measures in Aicardi Goutieres Syndrome
改善 Aicardi Goutieres 综合征的临床和生物学结果测量
  • 批准号:
    10675475
  • 财政年份:
    2019
  • 资助金额:
    $ 12.42万
  • 项目类别:
Optimizing Trial Readiness for Adrenomyeloneuropathy
优化肾上腺脊髓神经病的试验准备
  • 批准号:
    10675464
  • 财政年份:
    2019
  • 资助金额:
    $ 12.42万
  • 项目类别:
Improved clinical and biologic outcome measures in Aicardi Goutieres Syndrome
改善 Aicardi Goutieres 综合征的临床和生物学结果测量
  • 批准号:
    10023212
  • 财政年份:
    2019
  • 资助金额:
    $ 12.42万
  • 项目类别:
Administrative Unit for the GLIA-CTN
GLIA-CTN 行政单位
  • 批准号:
    10266085
  • 财政年份:
    2019
  • 资助金额:
    $ 12.42万
  • 项目类别:
Optimizing Trial Readiness for Adrenomyeloneuropathy
优化肾上腺脊髓神经病的试验准备
  • 批准号:
    10442670
  • 财政年份:
    2019
  • 资助金额:
    $ 12.42万
  • 项目类别:
Improved Outcome Assessments in Adrenomyeloneuropathy
改进肾上腺脊髓神经病的结果评估
  • 批准号:
    10675469
  • 财政年份:
    2019
  • 资助金额:
    $ 12.42万
  • 项目类别:
: Clinical Outcomes in Aicardi Goutières Syndrome
: Aicardi Goutières 综合征的临床结果
  • 批准号:
    10459505
  • 财政年份:
    2019
  • 资助金额:
    $ 12.42万
  • 项目类别:
Administrative Unit for the GLIA-CTN
GLIA-CTN 行政单位
  • 批准号:
    10923620
  • 财政年份:
    2019
  • 资助金额:
    $ 12.42万
  • 项目类别:

相似海外基金

Optimizing Health and Well-Being of Diverse Mothers with IDD and Their Infants During the Perinatal Period: A Virtual Advocate Tool for Data-Driven Supports
优化患有 IDD 的不同母亲及其婴儿在围产期的健康和福祉:用于数据驱动支持的虚拟倡导工具
  • 批准号:
    10760051
  • 财政年份:
    2023
  • 资助金额:
    $ 12.42万
  • 项目类别:
POSE: Phase II: Advocate Led Long-term Gameplan for Open OnDemand (ALL GOOD)
POSE:第二阶段:倡导者主导 Open OnDemand 的长期游戏计划(一切顺利)
  • 批准号:
    2303692
  • 财政年份:
    2023
  • 资助金额:
    $ 12.42万
  • 项目类别:
    Standard Grant
Capitalising on our differences: A gathering to better understand and advocate for Early Career Health Researchers in Canada
利用我们的差异:更好地理解和倡导加拿大早期职业健康研究人员的聚会
  • 批准号:
    468168
  • 财政年份:
    2022
  • 资助金额:
    $ 12.42万
  • 项目类别:
    Miscellaneous Programs
Addressing social adversity to improve outcomes among children undergoing liver transplant: the role for a health advocate on the transplant team
解决社会逆境以改善接受肝移植的儿童的预后:移植团队中健康倡导者的作用
  • 批准号:
    10427960
  • 财政年份:
    2022
  • 资助金额:
    $ 12.42万
  • 项目类别:
Evaluating an ACEs-Targeting Advocate Model of a Substance Use Prevention Program
评估药物使用预防计划的针对 ACE 的倡导者模型
  • 批准号:
    10577074
  • 财政年份:
    2022
  • 资助金额:
    $ 12.42万
  • 项目类别:
The Art of Creation: Using Art-Based Knowledge Translation to Promote and Advocate for a Healthy Start to Life
创造的艺术:利用基于艺术的知识转化来促进和倡导健康的生命开端
  • 批准号:
    486588
  • 财政年份:
    2022
  • 资助金额:
    $ 12.42万
  • 项目类别:
    Studentship Programs
When I am Old, I shall Wear Purple Nail Varnish: Utilising performance art to construct queer spaces that celebrate and advocate for ageing bodies
当我老了,我要涂紫色指甲油:利用行为艺术构建酷儿空间,庆祝和倡导衰老的身体
  • 批准号:
    2760091
  • 财政年份:
    2022
  • 资助金额:
    $ 12.42万
  • 项目类别:
    Studentship
Addressing social adversity to improve outcomes among children undergoing liver transplant: the role for a health advocate on the transplant team
解决社会逆境以改善接受肝移植的儿童的预后:移植团队中健康倡导者的作用
  • 批准号:
    10621188
  • 财政年份:
    2022
  • 资助金额:
    $ 12.42万
  • 项目类别:
Techquity by FAITH!: A cluster randomized controlled trial to assess the efficacy of a community-informed, cardiovascular health promotion mobile hlth intervention with digital health advocate support
Techquity by FAITH!:一项整群随机对照试验,旨在评估社区知情、心血管健康促进移动 hlth 干预措施在数字健康倡导者支持下的效果
  • 批准号:
    10891016
  • 财政年份:
    2021
  • 资助金额:
    $ 12.42万
  • 项目类别:
CMV responses in autoantibody positive subjects advocate antiviral treatments for prevention of T1D
自身抗体阳性受试者的 CMV 反应主张抗病毒治疗以预防 T1D
  • 批准号:
    10230365
  • 财政年份:
    2020
  • 资助金额:
    $ 12.42万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了